A New Perspective of Cannabinoid 1 Receptor Antagonists: Approaches Toward Peripheral CB1R Blockers without Crossing the Blood-Brain Barrier

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|11|12|1421-1429

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.11, Iss.12, 2011-06, pp. : 1421-1429

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Functional evidence for the ability of angiotensin AT 1 receptor antagonists to cross the blood-brain barrier in rats

By Polidori C.   Ciccocioppo R.   Pompei P.   Cirillo R.   Massi M.  

European Journal of Pharmacology, Vol. 307, Iss. 3, 1996-07 ,pp. : 259-267

Elsevier

Access to resources Recommend Favorite

Alterations in behavioral flexibility by cannabinoid CB1 receptor agonists and antagonists

By Hill Matthew   Froese Larissa   Morrish Anna   Sun Jane   Floresco Stan  

Psychopharmacology, Vol. 187, Iss. 2, 2006-08 ,pp. : 245-259

Springer Publishing Company

Access to resources Recommend Favorite

Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands

By  

Current Medicinal Chemistry, Vol. 21, Iss. 2, 2014-01 ,pp. : 187-203

Bentham Science Publishers

Access to resources Recommend Favorite

CB1 Cannabinoid Receptor Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 7, 2005-07 ,pp. : 631-640

Bentham Science Publishers

Access to resources Recommend Favorite

Relative efficacies of cannabinoid CB 1 receptor agonists in the mouse brain

By Burkey T.H.   Quock R.M.   Consroe P.   Ehlert F.J.   Hosohata Y.   Roeske W.R.   Yamamura H.I.  

European Journal of Pharmacology, Vol. 336, Iss. 2, 1997-10 ,pp. : 295-298

Elsevier

Access to resources Recommend Favorite